Abstract
Our society is currently experiencing increased lifespan; one of the top causes for the high incidence of neurodegenerative disorders. The lack of effective treatments delaying or blocking disease progression has encouraged the active search for novel therapies. Many evidences support the protective role of phytochemicals in the prevention of neurodegenerative diseases, particularly (poly)phenols. In this review, we described the use of cellular-based models of neurodegenerative diseases and the benefits of their use as potent tools in the search for bioactive molecules, particularly (poly)phenols. Studies to assess the biological activity of (poly)phenols involve experimentation with in vitro and in vivo systems. In vitro systems are a useful tool as a first approach to test the underlined molecular mechanisms of candidate molecules. They can provide valuable information about biological activity, which can be then used to design animal and human intervention studies.
Keywords: 2D and 3D cells models, neurodegenerative diseases, oxidative stress, polyphenol, yeast, phytochemicals.
Current Pharmaceutical Design
Title:Exploring the Benefits of Cellular Models to Uncover Bioactive Polyphenols for Neurodegeneration
Volume: 24 Issue: 19
Author(s): Rita Rosado-Ramos, Joana Godinho-Pereira, Ines Figueira, Carolina Jardim, Goncalo Garcia and Regina Menezes*
Affiliation:
- IBET, Instituto de Biologia Experimental e Tecnologica, Apartado 12, 2781-901 Oeiras,Portugal
Keywords: 2D and 3D cells models, neurodegenerative diseases, oxidative stress, polyphenol, yeast, phytochemicals.
Abstract: Our society is currently experiencing increased lifespan; one of the top causes for the high incidence of neurodegenerative disorders. The lack of effective treatments delaying or blocking disease progression has encouraged the active search for novel therapies. Many evidences support the protective role of phytochemicals in the prevention of neurodegenerative diseases, particularly (poly)phenols. In this review, we described the use of cellular-based models of neurodegenerative diseases and the benefits of their use as potent tools in the search for bioactive molecules, particularly (poly)phenols. Studies to assess the biological activity of (poly)phenols involve experimentation with in vitro and in vivo systems. In vitro systems are a useful tool as a first approach to test the underlined molecular mechanisms of candidate molecules. They can provide valuable information about biological activity, which can be then used to design animal and human intervention studies.
Export Options
About this article
Cite this article as:
Rosado-Ramos Rita , Godinho-Pereira Joana , Figueira Ines , Jardim Carolina , Garcia Goncalo and Menezes Regina *, Exploring the Benefits of Cellular Models to Uncover Bioactive Polyphenols for Neurodegeneration, Current Pharmaceutical Design 2018; 24 (19) . https://dx.doi.org/10.2174/1381612824666180629112148
DOI https://dx.doi.org/10.2174/1381612824666180629112148 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preventing Prion Pathogenicity by Targeting the Cellular Prion Protein
Infectious Disorders - Drug Targets Targeting ENaC as a Molecular Suspect in Cystic Fibrosis
Current Drug Targets Hematopoietic Stem Cells Therapies
Current Stem Cell Research & Therapy Left Anterior Temporal Lobe Sustains Naming in Alzheimers Dementia and Mild Cognitive Impairment
Current Alzheimer Research Biochemical Markers in CSF of ALS Patients
Current Medicinal Chemistry Involvement of Rat Hippocampal Astrocytes in β-Amyloid-Induced Angiogenesis and Neuroinflammation
Current Alzheimer Research Microglial Activation as a Compelling Target for Treating Acute Traumatic Brain Injury
Current Medicinal Chemistry Potential Targets for the Development of Novel Antidepressants: Future Perspectives
CNS & Neurological Disorders - Drug Targets Hybrid Molecules Synergistically Acting Against Protein Aggregation Diseases
Current Topics in Medicinal Chemistry Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions
Current Topics in Medicinal Chemistry Non-Globular Structures of Tandem Repeats in Proteins
Protein & Peptide Letters PET Tracers for Serotonin Receptors and Their Applications
Central Nervous System Agents in Medicinal Chemistry UCSF Small Molecule Discovery Center: Innovation, Collaboration and Chemical Biology in the Bay Area
Combinatorial Chemistry & High Throughput Screening Probing Cerebrovascular Alterations in Alzheimers Disease Using MRI: From Transgenic Models to Patients
Current Medical Imaging Towards A Multimodal Treatment of Depression: A Minireview on the Potential Role of Antibiotics
Mini-Reviews in Medicinal Chemistry Protein and Peptide Biopharmaceuticals: An Overview
Protein & Peptide Letters Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Patent Selections :
Recent Patents on Cardiovascular Drug Discovery Stimuli-Responsive Nanocarriers for Drug Delivery to the Central Nervous System
Current Nanoscience PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design